rs149478284

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_080860.4(RSPH1):​c.579A>G​(p.Arg193Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0362 in 1,613,592 control chromosomes in the GnomAD database, including 1,251 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.030 ( 92 hom., cov: 34)
Exomes 𝑓: 0.037 ( 1159 hom. )

Consequence

RSPH1
NM_080860.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 2.08

Publications

5 publications found
Variant links:
Genes affected
RSPH1 (HGNC:12371): (radial spoke head component 1) This gene encodes a male meiotic metaphase chromosome-associated acidic protein. This gene is expressed in tissues with motile cilia or flagella, including the trachea, lungs, airway brushings, and testes. Mutations in this gene result in primary ciliary dyskinesia-24. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2014]
RSPH1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 24
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 21-42477439-T-C is Benign according to our data. Variant chr21-42477439-T-C is described in ClinVar as Benign. ClinVar VariationId is 227051.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.09 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0296 (4515/152390) while in subpopulation NFE AF = 0.0415 (2822/68030). AF 95% confidence interval is 0.0402. There are 92 homozygotes in GnomAd4. There are 2265 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 92 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH1NM_080860.4 linkc.579A>G p.Arg193Arg synonymous_variant Exon 7 of 9 ENST00000291536.8 NP_543136.1 Q8WYR4-1
RSPH1NM_001286506.2 linkc.465A>G p.Arg155Arg synonymous_variant Exon 6 of 8 NP_001273435.1 Q8WYR4-2
RSPH1XM_011529786.2 linkc.507A>G p.Arg169Arg synonymous_variant Exon 6 of 8 XP_011528088.1
RSPH1XM_005261208.3 linkc.372A>G p.Arg124Arg synonymous_variant Exon 5 of 7 XP_005261265.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH1ENST00000291536.8 linkc.579A>G p.Arg193Arg synonymous_variant Exon 7 of 9 1 NM_080860.4 ENSP00000291536.3 Q8WYR4-1
RSPH1ENST00000398352.3 linkc.465A>G p.Arg155Arg synonymous_variant Exon 6 of 8 5 ENSP00000381395.3 Q8WYR4-2
RSPH1ENST00000493019.1 linkn.2197A>G non_coding_transcript_exon_variant Exon 6 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.0297
AC:
4520
AN:
152272
Hom.:
92
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00694
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0224
Gnomad ASJ
AF:
0.0608
Gnomad EAS
AF:
0.000576
Gnomad SAS
AF:
0.0329
Gnomad FIN
AF:
0.0533
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0415
Gnomad OTH
AF:
0.0339
GnomAD2 exomes
AF:
0.0336
AC:
8435
AN:
251312
AF XY:
0.0356
show subpopulations
Gnomad AFR exome
AF:
0.00622
Gnomad AMR exome
AF:
0.0176
Gnomad ASJ exome
AF:
0.0613
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.0501
Gnomad NFE exome
AF:
0.0397
Gnomad OTH exome
AF:
0.0365
GnomAD4 exome
AF:
0.0369
AC:
53934
AN:
1461202
Hom.:
1159
Cov.:
33
AF XY:
0.0375
AC XY:
27274
AN XY:
726916
show subpopulations
African (AFR)
AF:
0.00535
AC:
179
AN:
33474
American (AMR)
AF:
0.0187
AC:
836
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0615
AC:
1608
AN:
26128
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.0411
AC:
3540
AN:
86232
European-Finnish (FIN)
AF:
0.0483
AC:
2579
AN:
53352
Middle Eastern (MID)
AF:
0.0392
AC:
226
AN:
5766
European-Non Finnish (NFE)
AF:
0.0385
AC:
42751
AN:
1111446
Other (OTH)
AF:
0.0366
AC:
2212
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
2431
4863
7294
9726
12157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1532
3064
4596
6128
7660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0296
AC:
4515
AN:
152390
Hom.:
92
Cov.:
34
AF XY:
0.0304
AC XY:
2265
AN XY:
74524
show subpopulations
African (AFR)
AF:
0.00690
AC:
287
AN:
41606
American (AMR)
AF:
0.0223
AC:
342
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0608
AC:
211
AN:
3472
East Asian (EAS)
AF:
0.000578
AC:
3
AN:
5194
South Asian (SAS)
AF:
0.0327
AC:
158
AN:
4832
European-Finnish (FIN)
AF:
0.0533
AC:
566
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0415
AC:
2822
AN:
68030
Other (OTH)
AF:
0.0336
AC:
71
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
235
471
706
942
1177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0378
Hom.:
58
Bravo
AF:
0.0261
Asia WGS
AF:
0.0160
AC:
54
AN:
3478
EpiCase
AF:
0.0405
EpiControl
AF:
0.0418

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 06, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Arg193Arg in exon 7 of RSPH1: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 4.4% (376/8600) of E uropean American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs149478284). -

Primary ciliary dyskinesia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.59
CADD
Benign
7.0
DANN
Benign
0.73
PhyloP100
2.1
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149478284; hg19: chr21-43897549; COSMIC: COSV52319309; API